Nachrichten zur Pacific Biosciences of California Aktie

CORRECTION - Pacific Biosciences of California, Inc. Fourth Quarter 2019 Financial Results Call

MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same…

Pacific Biosciences of California, Inc. Fourth Quarter 2019 Financial Results Call

MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold…

Illumina Stock Slips on Pacific Biosciences Deal Termination

Per Illumina (ILMN), the lengthy route to achieve regulatory nods for the transaction induces uncertainty about the ultimate outcome of…

Illumina and Pacific Biosciences Call the Whole Thing Off. Shares Barely React.

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina, Pacific Biosciences of California End Plans to Combine

Illumina, a next-generation DNA sequencing company, has called off its plans to buy nascent competitor Pacific Biosciences of California....…

Illumina bläst Übernahme ab - und jetzt-

Es hat sich in den letzten Monaten bereits abgezeichnet: Illumina muss die geplante Milliarden-Übernahme von Pacific Biosciences absagen. Bei den…

DNA-sequencing companies Illumina and Pacific Biosciences have called off their planned $1.2 billion merger

Um den gesamten Artikel unter trib.al zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina abandons $1.2 billion deal to buy rival Pacific Biosciences

In its complaint last month, the FTC raised concerns that Illumina wanted the deal in order to prevent Pacific Biosciences…

Illumina abandons $1.2 bln deal to buy rival Pacific Biosciences

Illumina Inc on Thursday agreed to terminate the $1.2 billion deal to buy smaller rival Pacific Biosciences of California Inc, weeks after…

Illumina, Pacific Biosciences drop $1.2 billion merger agreement

Illumina Inc. and Pacific Biosciences of California Inc. on Thursday said they have agreed to drop plans to…

Illumina, Pacific Biosciences terminate merger agreement

Illumina and Pacific Biosciences have decided to terminate their $1.2B merger agreement due to a lengthy approval process. CNBC's Meg…

Heres Why You Should Retain Pacific Biosciences Stock Now

Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, stiff competition remains a woe....…

What Happens Next for Illumina and Pacific Biosciences-

The failed acquisition of Pacific Biosciences increases the pressure on a technology platform that may not be a perfect fit…

Pacific Biosciences stock falls on FTC challenge to Illumina deal

Shares of Pacific Biosciences of California Inc. tumbled 3% in morning trading the day after the Federal Trade Commission…

Federal Trade Commission Challenges Illuminas Proposed Acquisition of Pacific Biosciences

The Federal Trade Commission said it is challenging Illumina Inc.s proposed $1.2 billion deal to buy Pacific Biosciences of California,…

Pacific Biosciences (PACB) Up 2.7% Since Last Earnings Report: Can It Continue-

Pacific Biosciences (PACB) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Heres Why You Should Hold on to Pacific Biosciences Stock

Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, stiff competition remains a woe....…

Heres Why Pacific Biosciences Gained as Much as 10.5% Today

Illumina just proposed the nuclear option to earn regulatory approval for its merger and keep its biggest competitor at bay....…

Pacific Biosciences (PACB) Q3 Loss Wider Than Estimates

Pacific Biosciences (PACB) gains from solid segmental contributions in the third quarter....…

Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -26.67% and -21.80%, respectively, for the quarter ended September 2019. Do…

Pacific Biosciences of California EPS misses by $0.05, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Merger Arbitrage Mondays - Pacific Biosciences Drops After U.K.s Competition And Markets Authority Raises Concerns

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The U.K.S Antitrust Regulator Seems Bent On Blocking The Pacific Biosciences - Illumina Deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Pacific Biosciences of California Stock Is Sinking Today

News that the U.K. could scuttle its merger with Illumina has investors worried....…

Pacific Biosciences and Illumina extend merger deadline to March 31, 2020

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heres Why You Should Retain Pacific Biosciences For Now

Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, contraction in gross margin remains a…

Merger or Not, Pacific Biosciences Needs to Deliver

The DNA sequencing pioneer promised a $1,000 human genome by early 2019. The price isnt so important, but the technology…

Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 11.11% and 10.58%, respectively, for the quarter ended June 2019. Do…

What Happens If Pacific Biosciences Isnt Acquired By Illumina-

Abandoning the proposed deal would have a seismic effect on the future of DNA sequencing, but its not all bad…

Why J.C. Penney, QEP Resources, and Pacific Biosciences Slumped Today

Bad news on several different fronts held these stocks back....…

Heres Why Pacific Biosciences Is Tumbling Today

Trade investigations and a stumbling patent portfolio have investors growing anxious about the pending acquisition by Illumina....…

UKs CMA refers Illumina-Pacific Biosciences deal for in-depth investigation

Britains competition watchdog said on Thursday it would launch an in-depth investigation into the planned $1.2 billion merger between gene sequencing company Illumina…

The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health

The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health...…

Pacific Biosciences Stumbles As The U.K. Raises Concerns About Illuminas Bid

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-UKs CMA says Illumina-Pacific Biosciences deal could hurt competition

Britains competition watchdog said on Tuesday the planned $1.2 billion merger between gene sequencing company Illumina Inc and smaller rival Pacific Biosciences of…

UKs CMA says Illumina-Pacific Biosciences deal could hurt competition

Britains competition watchdog said on Tuesday the planned $1.2 billion merger between gene sequencing company Illumina Inc and smaller rival Pacific Biosciences of…

Pacific Biosciences (PACB) Down 7.8% Since Last Earnings Report: Can It Rebound-

Pacific Biosciences (PACB) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Pacific Biosciences (PACB) Incurs Loss in Q1, Revenues Fall

Pacific Biosciences (PACB) segments see softness in Q1; merger with Illumina on track....…

Pump the Brakes on the Illumina and Pacific Biosciences Deal

The United Kingdoms Competition and Markets Authority has opened an investigation into the acquisition. What happens now?...…

Pacific Biosciences (PACB) Up 3.8% Since Last Earnings Report: Can It Continue-

Pacific Biosciences (PACB) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Pacific Biosciences of California (PACB) Reports Q4 Loss, Lags Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -61.54% and -7.37%, respectively, for the quarter ended December 2018. Do…

Heres Why You Should Hold Pacific Biosciences (PACB) Now

Pacific Biosciences (PACB) is likely to gain from strong prospects in the Sequel System platform. However, the company faces cutthroat…

Pacific Biosciences Offers Insights on Aedes aegypti Genome

Pacific Biosciences (PACB) uses its flagship Single Molecule, Real-Time technology to sequence the highest quality genome assembly for the Aedes…

Is This the Real Reason Illumina Acquired Pacific Biosciences-

The $1.2 billion acquisition will combine the two leading DNA sequencing technology platforms, but the battle for the future of…

Why Alkermes Depression Drug Stumbled, and How Illumina Plans to Profit From M&A

Heres what derailed the drug, and why Illumina is paying $1.2 billion to acquire Pacific Biosciences....…

Pacific Biosciences (PACB) Reports Q3 Loss, Revenues Fall Y/Y

Pacific Biosciences (PACB) is getting acquired by Illumina (ILMN) by mid-2019....…

Illumina (ILMN) Inks $1.2B Deal to Buy Pacific Biosciences

Illumina (ILMN) taking out on its peer, in the $1.2-billion acquisition deal, will further strengthen the position of the former…

Illumina, Inc. (ILMN) CEO Francis deSouza Hosts Acquisition of Pacific Biosciences Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heres Why Illimuna Just Bought Its Biggest Competitor

Illumina surprised investors this week by announcing its buying Pacific Biosciences. Heres how the deal could move the needle for…

Why Newell Brands, VeriSign, and Pacific Biosciences of California Jumped Today

Find out which of these stocks got a buyout bid....…